Statewide COVID-19 Disaster Expiration

Translate to Spanish or other 102 languages!

Governor Abbott’s statewide disaster declaration related to the COVID-19 pandemic expired on June 15, 2023. As a result, ALL rule waivers are no longer active as of this date. Image for illustration purposes

Mega Doctor News

- Advertisement -

Emergency Visiting Physician Temporary Permits will remain in effect for an additional 30 days after the termination of the disaster declaration to allow permit holders and health care entities to properly plan. Therefore, current authorized Emergency VPTPs, and any emergency reactivations for retired or cancelled licenses, will terminate on July 14, 2023, and permit holders who do not have an active permit or license with the Board must cease practice in Texas. 

The following additional rule waivers are no longer in effect as of 6/15/2023: 

  • Telemedicine Waiver: allowed providers to establish a physician-patient relationship via telephone (audio-only) and enabled phone consults to diagnose, treat, order tests, and prescribe. 
  • Limits on Number of Delegates: waived the delegate limit of seven PAs or APRNs that a physician could supervise and delegate to regardless of location or setting. 
  • PITs: allowed Texas hospitals and facilities associated with Graduate Medical Education (GME) training programs to be able to utilize Physician in Training (PIT) permit holders in areas outside of their GME training program to respond to COVID-19. 
- Advertisement -
- Advertisement -

- Advertisement -

More Articles

DHR Health Expands Kidney Transplant Program with Transplant Nephrologist, Dr. Victor E. Prado

As part of its ongoing commitment to bringing world-class healthcare to the Rio Grande Valley, DHR Health is pleased to announce the addition of double board-certified transplant nephrologist, Dr. Victor E. Prado. Dr. Prado will provide care to patients at DHR Health’s Transplant Institute,

New Therapy for Head and Neck Squamous Cell Carcinoma Receives Accelerated FDA Approval

The U.S. Food and Drug Administration today granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) whose disease has progressed on or after platinum-based chemotherapy and immunotherapy.

The Rio Grande Valley Makes Its Voice Heard

 Voter participation increased substantially across four Rio Grande Valley counties during the November 3, 2026, general election, according to preliminary figures released by the Advocacy Alliance Center of Texas (AACT NOW), a nonprofit organization promoting nonpartisan civic engagement.

STHS Heart Ranked Among Texas’ Top 5 Hospitals for Coronary Intervention

For Valley residents, STHS Heart continues to distinguish itself through nationally recognized heart and vascular services and a commitment to delivering high-quality, compassionate care close to home.
- Advertisement -